Safety Study of Adjuvant Vaccine to Treat Melanoma Patients
Clinical trial NCT01079741 · COMPLETED
Trial details
- NCT number
- NCT01079741
- Sponsor
- Nina Bhardwaj
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2013-03-11
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.